Aquisition: TrustedID

We are pleased to announce the sale of TrustedID, a leading provider of identify theft protection, to Equifax, one of the largest sources of credit data in the world. TrustedID will join the Equifax Personal Solutionsteam and continue to market their products directly to customers. As big fans of Scott Mitic and his team, we wish them the very best going forward in their new roles.

Aquisition: TrustedID

New Investment: AtTask

UVF is pleased to announce our investment in AtTask alongside Greenspring Associates, Escalate Capital and Josh James. AtTask is an industry leader in Software-As-A-Service (SaaS) project and work management solutions. This funding will be used to fuel ongoing growth as the company cements its position as a market leader.

New Investment: AtTask

IPO: Merrimack Pharmaceuticals

University Venture Fund (UVF) is pleased to announce the initial public offering of Merrimack Pharmaceuticals (MACK). Merrimack is a cancer research and pharmaceutical company based in Boston, Massachusetts. MACK has developed a portfolio of cancer treatment drugs and is currently seeking FDA approval for several. This marks the 3rd IPO for the UVF portfolio.  

IPO: Merrimack Pharmaceuticals

IPO: Control4

We are excited to cheer on Control4, a leader in home automation, with their recent initial public offering. Read more about it here.

IPO: Control4

    Who We Are

    "If this were around when I was in school, I'd probably still be in school."
    - Warren Buffett


    The University Venture Fund offers the opportunity to work alongside premier venture capital firms and entrepreneurs across the nation as students perform detailed due diligence and deploy capital into emerging technologies and growing businesses.